Araştırma Makalesi
BibTex RIS Kaynak Göster

Relationships Between Perceived Social Support and Treatment Adherence in TYPE-2 Diabetes Patients

Yıl 2024, Cilt: 15 Sayı: 1, 46 - 53, 31.01.2024
https://doi.org/10.31067/acusaglik.1340686

Öz

Background/Purpose: Type-2 Diabetes is a disease that may cause many complications or even early mortality. Thus, adherence to treatment is crucial for people with Type-2 Diabetes. Treatment regimens for diabetes include many steps like controlling for blood sugar levels and exercising and also it is known that support from the environment might motivate patients to adhere to their treatment regimens more. Accordingly, the purpose of the current research article is to understand the relationships between perceived social support and treatment adherence in Type-2 Diabetes patients.
Methods: After obtaining the necessary ethical approval, I administered surveys to 119 Type-2 Diabetes patients.
Results: I found that patients who feel more support from their significant ones adhere to their treatment regimens significantly more.
Conclusion: This result shows the importance of social support for Type 2 Diabetes patients. Thus, in the future researchers might try to understand how people make those people suffer from diseases feel more supported and create some intervention programs accordingly.

Kaynakça

  • 1. Kaul, K., Tarr, J.M., Ahmad, S.I., Kohner, E.M., Chibber, R. (2013). Introduction to Diabetes Mellitus. In: Ahmad, S.I. (eds) Diabetes. Advances in Experimental Medicine and Biology, vol 771. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5441-0_1
  • 2. International Diabetes Federation. Diabetes and impaired glucose tolerance. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: International Diabetes Federation, 2021. Retrieved July 27, 2023, from https://diabetesatlas.org/idfawp/resourcefiles/2021/07/IDF_Atlas_10th_Edition_2021.pdf
  • 3. Vivian, E. M. (2006). Type 2 diabetes in children and adolescents - The next epidemic? Current Medical Research and Opinion, 22(2), 297–306. https://doi.org/10.1185/030079906X80495
  • 4. Rao Kondapally Seshasai, S., Kaptoge, S., Thomp-son, A., di Angelantonio, E., Gao, P.,Sarwar, N., Fletch-er, A., Lewington, S., Collins, R., Selvin, E., & Danesh, J. (2011). Diabetes mellitus, fasting glucose, and risk of cause-specific death. The New England Journal of Medicine, 364, 829-841. https://doi.org/10.1056/NEJMoa1008862
  • 5. Patel, S. A., Ali, M. K., Alam, D., Yan, L. L., Levitt, N. S., Bernabe-Ortiz, A., Checkley, W., Wu, Y., Irazola, V., Gutierrez, L., Rubinstein, A., Shivashankar, R., Li, X., Miranda, J. J., Chowdhury, M. A., Siddiquee, A. T., Gaziano, T. A., Kadir, M. M., & Prabhakaran, D. (2016). Obesity and its relation with diabetes and hypertension: A cross-sectional study across 4 geographical regions. Global Heart, 11(1), 71–79. https://doi.org/10.1016/j.gheart.2016.01.003
  • 6. World Health Organization (WHO). (2003). Adherence to long-term therapies : evidence for action. Retrieved July 28, 2023, from https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf?sequence=1&isAllowed=y
  • 7. Dimatteo, M. R., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002). Patient adherence and medical treatment outcomes: A meta-analysis. Medical Care, 40(9), 794–811. https://doi.org/10.1097/01.MLR.0000024612.61915.2D
  • 8. Kankeu, H. T., Saksena, P., Xu, K., & Evans, D. B. (2013). The financial burden from non-communicable diseases in low- and middle-income countries: A literature review. Health Research Policy and Systems, 11(1), open access. https://doi.org/10.1186/1478-4505-11-31
  • 9. Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000). The summary of diabetes self-care activities measure: Results from 7 studies and a revised scale. Diabetes Care, 23(7), 943–950. https://doi.org/10.2337/diacare.23.7.943
  • 10. Rubin, R. R., & Peyrot, M. (2001). Psychological issues and treatments for people with diabetes. Journal of Clinical Psychology, 57(4), 457–478. https://doi.org/10.1002/jclp.1041
  • 11. Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., Mcclure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006). Effect of medication non-adherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine, 166(17), 1836–1841. https://doi.org/10.1001/archinte.166.17.1836
  • 12. Ratanawongsa, N., Karter, A. J., Parker, M. M., Lyles, C. R., Heisler, M., Moffet, H. H., Adler, N., Warton, E. M., & Schillinger, D. (2013). Communication and medication refill adherence: the Diabetes Study of Northern California. JAMA Internal Medicine, 173(3), 210–218. https://doi.org/10.1001/jamainternmed.2013.1216
  • 13. Elliott, W. J., Maddy, R., Toto, R., & Bakris, G. (2000). Hypertension in patients with diabetes. Overcoming barriers to effective control. Postgraduate Medicine, 107(3), 29–38. https://doi.org/10.3810/pgm.2000.03.940
  • 14. Guillausseau, P.J. (2003) Influence of oral anti-diabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes & Metabolism, 29, 79-81. http://dx.doi.org/10.1016/S1262-3636(07)70011-3
  • 15. Rozenfeld, Y., Hunt, J. S., Plauschinat, C., & Wong, K. S. (2008). Oral antidiabetic medication adherence and glycemic control in managed care. The American Journal of Managed Care, 14(2), 71–75. Retrieved July 28, 2023, from https://www.ncbi.nlm.nih.gov/pubmed/18269302
  • 16. Bailey, C. J., & Kodack, M. (2011). Patient adherence to medication requirements for therapy of type 2 diabetes. International Journal of Clinical Practice, 65(3) 314–322. https://doi.org/10.1111/j.1742-1241.2010.02544.x
  • 17. García-Pérez, L. E., Alvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013). Adherence to therapies in patients with type 2 diabetes. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders, 4(2), 175–194. https://doi.org/10.1007/s13300-013-0034-y
  • 18. Simon, D., de Pablos-Velasco, P., Parhofer, K. G., Gönder-Frederick, L., Duprat Lomon, I., Vandenberghe, H., Eschwège, E., & Bradley, C. (2015). Hypoglycaemic episodes in patients with type 2 diabetes--risk factors and associations with patient-reported outcomes: The PANORAMA Study. Diabetes & Metabolism, 41(6), 470–479. https://doi.org/10.1016/j.diabet.2015.08.007
  • 19. Adisa, R., Olajide, O. O., & Fakeye, T. O. (2017). Social support, treatment adherence and outcome among hypertensive and type 2 diabetes patients in ambulatory care settings in southwestern Nigeria. Ghana Medical Journal, 51(2), 64–77. https://doi.org/10.4314/gmj.v51i2.4
  • 20. Glasgow, R. E., Toobert, D. J., & Gillette, C. D. (2001). Psychosocial barriers to diabetes self- management and quality of life. Diabetes Spectrum, 14(1), 33-41. https://doi.org/10.2337/diaspect.14.1.33
  • 21. Shumaker, S. A., & Brownell, A. (1984). Toward a theory of social support: Closing conceptual gaps. Journal of Social Issues, 40(4), 11–36. https://doi.org/10.1111/j.1540-4560.1984.tb01105.x
  • 22. Strom, J. L., & Egede, L. E. (2012). The impact of social support on outcomes in adult patients with type 2 diabetes: A systematic review. Current Diabetes Reports, 12(6), 769–781. https://doi.org/10.1007/s11892-012-0317-0
  • 23. Tang, T. S., Brown, M. B., Funnell, M. M., Anderson, R. M. (2008). Social support, quality of life, and self-care behaviors among African Americans with type 2 diabetes. The Diabetes Educator, 34(2):266-276. https://doi.org/:10.1177/0145721708315680
  • 24. Kim, M. T., Kim, K. B., Huh, B., Nguyen, T., Han, H. R., Bone, L. R., & Levine, D. (2015). The effect of a community-based self-help ıntervention: Korean Americans with type 2 diabetes. American Journal of Preventive Medicine, 49(5), 726–737. https://doi.org/10.1016/j.amepre.2015.04.033
  • 25. Zimet, G. D., Dahlem, N. W., Zimet, S. G., & Farley, G. K. (1988). The Multidimensional Scale of Perceived Social Support. Journal of Personality Assessment, 52(1), 30–41. https://doi.org/10.1207/s15327752jpa5201_2
  • 26. Eker, D., & Arkar, H. (1995). Perceived social support: Psychometric properties of the MSPSS in normal and pathological groups in a developing country. Social Psychiatry and Psychiatric Epidemiology: The International Journal for Research in Social and Genetic Epidemiology and Mental Health Services, 30(3), 121–126. https://doi.org/10.1007/BF00802040
  • 27. Eker, D., Arkar, H., & Yaldız, H. (2001). Çok Boyutlu Algılanan Sosyal Destek Ölçeği’nin gözden geçirilmiş formunun faktör yapısı, geçerlik ve güvenirliği. Türk Psikiyatri Dergisi, 12(1), 17-25.
  • 28. Gatt, S., & Sammut, R. (2008). An exploratory study of predictors of self-care behaviour in persons with type 2 diabetes. International Journal of Nursing Studies, 45(10), 1525–1533. https://doi.org/10.1016/j.ijnurstu.2008.02.006
  • 29. Dilekler, İ., Doğulu, C., & Bozo, Ö. (2021). A test of theory of planned behavior in type II diabetes adherence: The leading role of perceived behavioral control. Current Psychology, 40(7), 3546–3555. https://doi.org/10.1007/s12144-019-00309-7
  • 30. Yalçin, G. Y., Beşer, A., & Kürtüncü, M. (2022). Evaluation of the relationship between socio-demographic characteristics and social support with adherence to treatment in patient with Multiple Sclerosis. International Journal of Disabilities Sports and Health Sciences, 5(2), 75–82. https://doi.org/10.33438/ijdshs.1105516
Yıl 2024, Cilt: 15 Sayı: 1, 46 - 53, 31.01.2024
https://doi.org/10.31067/acusaglik.1340686

Öz

Teşekkür

Katkılarından dolayı Prof. Dr. Özlem Bozo'ya teşekkür ederim.

Kaynakça

  • 1. Kaul, K., Tarr, J.M., Ahmad, S.I., Kohner, E.M., Chibber, R. (2013). Introduction to Diabetes Mellitus. In: Ahmad, S.I. (eds) Diabetes. Advances in Experimental Medicine and Biology, vol 771. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5441-0_1
  • 2. International Diabetes Federation. Diabetes and impaired glucose tolerance. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: International Diabetes Federation, 2021. Retrieved July 27, 2023, from https://diabetesatlas.org/idfawp/resourcefiles/2021/07/IDF_Atlas_10th_Edition_2021.pdf
  • 3. Vivian, E. M. (2006). Type 2 diabetes in children and adolescents - The next epidemic? Current Medical Research and Opinion, 22(2), 297–306. https://doi.org/10.1185/030079906X80495
  • 4. Rao Kondapally Seshasai, S., Kaptoge, S., Thomp-son, A., di Angelantonio, E., Gao, P.,Sarwar, N., Fletch-er, A., Lewington, S., Collins, R., Selvin, E., & Danesh, J. (2011). Diabetes mellitus, fasting glucose, and risk of cause-specific death. The New England Journal of Medicine, 364, 829-841. https://doi.org/10.1056/NEJMoa1008862
  • 5. Patel, S. A., Ali, M. K., Alam, D., Yan, L. L., Levitt, N. S., Bernabe-Ortiz, A., Checkley, W., Wu, Y., Irazola, V., Gutierrez, L., Rubinstein, A., Shivashankar, R., Li, X., Miranda, J. J., Chowdhury, M. A., Siddiquee, A. T., Gaziano, T. A., Kadir, M. M., & Prabhakaran, D. (2016). Obesity and its relation with diabetes and hypertension: A cross-sectional study across 4 geographical regions. Global Heart, 11(1), 71–79. https://doi.org/10.1016/j.gheart.2016.01.003
  • 6. World Health Organization (WHO). (2003). Adherence to long-term therapies : evidence for action. Retrieved July 28, 2023, from https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf?sequence=1&isAllowed=y
  • 7. Dimatteo, M. R., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002). Patient adherence and medical treatment outcomes: A meta-analysis. Medical Care, 40(9), 794–811. https://doi.org/10.1097/01.MLR.0000024612.61915.2D
  • 8. Kankeu, H. T., Saksena, P., Xu, K., & Evans, D. B. (2013). The financial burden from non-communicable diseases in low- and middle-income countries: A literature review. Health Research Policy and Systems, 11(1), open access. https://doi.org/10.1186/1478-4505-11-31
  • 9. Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000). The summary of diabetes self-care activities measure: Results from 7 studies and a revised scale. Diabetes Care, 23(7), 943–950. https://doi.org/10.2337/diacare.23.7.943
  • 10. Rubin, R. R., & Peyrot, M. (2001). Psychological issues and treatments for people with diabetes. Journal of Clinical Psychology, 57(4), 457–478. https://doi.org/10.1002/jclp.1041
  • 11. Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., Mcclure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006). Effect of medication non-adherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine, 166(17), 1836–1841. https://doi.org/10.1001/archinte.166.17.1836
  • 12. Ratanawongsa, N., Karter, A. J., Parker, M. M., Lyles, C. R., Heisler, M., Moffet, H. H., Adler, N., Warton, E. M., & Schillinger, D. (2013). Communication and medication refill adherence: the Diabetes Study of Northern California. JAMA Internal Medicine, 173(3), 210–218. https://doi.org/10.1001/jamainternmed.2013.1216
  • 13. Elliott, W. J., Maddy, R., Toto, R., & Bakris, G. (2000). Hypertension in patients with diabetes. Overcoming barriers to effective control. Postgraduate Medicine, 107(3), 29–38. https://doi.org/10.3810/pgm.2000.03.940
  • 14. Guillausseau, P.J. (2003) Influence of oral anti-diabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes & Metabolism, 29, 79-81. http://dx.doi.org/10.1016/S1262-3636(07)70011-3
  • 15. Rozenfeld, Y., Hunt, J. S., Plauschinat, C., & Wong, K. S. (2008). Oral antidiabetic medication adherence and glycemic control in managed care. The American Journal of Managed Care, 14(2), 71–75. Retrieved July 28, 2023, from https://www.ncbi.nlm.nih.gov/pubmed/18269302
  • 16. Bailey, C. J., & Kodack, M. (2011). Patient adherence to medication requirements for therapy of type 2 diabetes. International Journal of Clinical Practice, 65(3) 314–322. https://doi.org/10.1111/j.1742-1241.2010.02544.x
  • 17. García-Pérez, L. E., Alvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013). Adherence to therapies in patients with type 2 diabetes. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders, 4(2), 175–194. https://doi.org/10.1007/s13300-013-0034-y
  • 18. Simon, D., de Pablos-Velasco, P., Parhofer, K. G., Gönder-Frederick, L., Duprat Lomon, I., Vandenberghe, H., Eschwège, E., & Bradley, C. (2015). Hypoglycaemic episodes in patients with type 2 diabetes--risk factors and associations with patient-reported outcomes: The PANORAMA Study. Diabetes & Metabolism, 41(6), 470–479. https://doi.org/10.1016/j.diabet.2015.08.007
  • 19. Adisa, R., Olajide, O. O., & Fakeye, T. O. (2017). Social support, treatment adherence and outcome among hypertensive and type 2 diabetes patients in ambulatory care settings in southwestern Nigeria. Ghana Medical Journal, 51(2), 64–77. https://doi.org/10.4314/gmj.v51i2.4
  • 20. Glasgow, R. E., Toobert, D. J., & Gillette, C. D. (2001). Psychosocial barriers to diabetes self- management and quality of life. Diabetes Spectrum, 14(1), 33-41. https://doi.org/10.2337/diaspect.14.1.33
  • 21. Shumaker, S. A., & Brownell, A. (1984). Toward a theory of social support: Closing conceptual gaps. Journal of Social Issues, 40(4), 11–36. https://doi.org/10.1111/j.1540-4560.1984.tb01105.x
  • 22. Strom, J. L., & Egede, L. E. (2012). The impact of social support on outcomes in adult patients with type 2 diabetes: A systematic review. Current Diabetes Reports, 12(6), 769–781. https://doi.org/10.1007/s11892-012-0317-0
  • 23. Tang, T. S., Brown, M. B., Funnell, M. M., Anderson, R. M. (2008). Social support, quality of life, and self-care behaviors among African Americans with type 2 diabetes. The Diabetes Educator, 34(2):266-276. https://doi.org/:10.1177/0145721708315680
  • 24. Kim, M. T., Kim, K. B., Huh, B., Nguyen, T., Han, H. R., Bone, L. R., & Levine, D. (2015). The effect of a community-based self-help ıntervention: Korean Americans with type 2 diabetes. American Journal of Preventive Medicine, 49(5), 726–737. https://doi.org/10.1016/j.amepre.2015.04.033
  • 25. Zimet, G. D., Dahlem, N. W., Zimet, S. G., & Farley, G. K. (1988). The Multidimensional Scale of Perceived Social Support. Journal of Personality Assessment, 52(1), 30–41. https://doi.org/10.1207/s15327752jpa5201_2
  • 26. Eker, D., & Arkar, H. (1995). Perceived social support: Psychometric properties of the MSPSS in normal and pathological groups in a developing country. Social Psychiatry and Psychiatric Epidemiology: The International Journal for Research in Social and Genetic Epidemiology and Mental Health Services, 30(3), 121–126. https://doi.org/10.1007/BF00802040
  • 27. Eker, D., Arkar, H., & Yaldız, H. (2001). Çok Boyutlu Algılanan Sosyal Destek Ölçeği’nin gözden geçirilmiş formunun faktör yapısı, geçerlik ve güvenirliği. Türk Psikiyatri Dergisi, 12(1), 17-25.
  • 28. Gatt, S., & Sammut, R. (2008). An exploratory study of predictors of self-care behaviour in persons with type 2 diabetes. International Journal of Nursing Studies, 45(10), 1525–1533. https://doi.org/10.1016/j.ijnurstu.2008.02.006
  • 29. Dilekler, İ., Doğulu, C., & Bozo, Ö. (2021). A test of theory of planned behavior in type II diabetes adherence: The leading role of perceived behavioral control. Current Psychology, 40(7), 3546–3555. https://doi.org/10.1007/s12144-019-00309-7
  • 30. Yalçin, G. Y., Beşer, A., & Kürtüncü, M. (2022). Evaluation of the relationship between socio-demographic characteristics and social support with adherence to treatment in patient with Multiple Sclerosis. International Journal of Disabilities Sports and Health Sciences, 5(2), 75–82. https://doi.org/10.33438/ijdshs.1105516
Toplam 30 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Halk Sağlığı (Diğer)
Bölüm Araştırma Makaleleri
Yazarlar

Derya Karataş 0000-0001-7734-7270

Yayımlanma Tarihi 31 Ocak 2024
Gönderilme Tarihi 10 Ağustos 2023
Yayımlandığı Sayı Yıl 2024Cilt: 15 Sayı: 1

Kaynak Göster

EndNote Karataş D (01 Ocak 2024) Relationships Between Perceived Social Support and Treatment Adherence in TYPE-2 Diabetes Patients. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 15 1 46–53.